mrc1 Antibody

What is MRC1 and what is its biological significance?

MRC1, also known as CD206 or Macrophage Mannose Receptor (MMR), is a 162-175 kDa type I transmembrane glycoprotein that functions as a pattern recognition receptor. It belongs to the Group VI C-type lectins along with CD280, CD205, and the phospholipase A2 receptor . Structurally, MRC1 consists of:

• An N-terminal cysteine-rich ricin b-type lectin domain

• A fibronectin type II domain

• Eight tandemly arranged C-type lectin-like domains (CTLDs)

• A transmembrane domain

• A cytoplasmic domain

Functionally, MRC1 mediates the endocytosis of glycoproteins by macrophages, binding both sulfated and non-sulfated polysaccharide chains. It acts as a phagocytic receptor for bacteria, fungi, and other pathogens . The terminal cysteine-rich domain binds sulfated sugars, while CTLDs 4-8 recognize polysaccharides terminated in mannose, fucose, or N-acetylglucosamine—structures commonly found on microorganisms and some endogenous glycoproteins .

What types of MRC1 antibodies are available for research?

Several types of MRC1 antibodies are available for research applications:

• Monoclonal antibodies: These include clone 15-2 (also known as MR15-2), which recognizes an extracellular epitope of CD206, and clone 7-450, which is specifically designed for frozen immunohistochemical sections .

• Polyclonal antibodies: For example, rabbit polyclonal antibodies like bs-4727r, which are raised against synthetic peptides derived from human MRC1 .

• Conjugated antibodies: MRC1 antibodies are available with various conjugations, including:

  • Unconjugated antibodies

  • PE (phycoerythrin) conjugated

  • FITC (fluorescein isothiocyanate) conjugated

The choice between these antibody types depends on the specific application, with monoclonal antibodies offering high specificity for a single epitope, while polyclonal antibodies may provide improved sensitivity by recognizing multiple epitopes.

What applications are MRC1 antibodies suitable for?

MRC1 antibodies can be utilized in numerous research applications:

The mouse monoclonal antibody 15-2 is particularly versatile, excelling in applications such as flow cytometry, western blotting, and immunohistochemistry . The rabbit polyclonal antibody bs-4727r is recommended for WB at dilutions of 1:300-5000, ELISA at 1:500-1000, and flow cytometry at 1:20-100 .

Which cell types and tissues express MRC1?

MRC1 expression is predominantly found on:

• Antigen-presenting cells:

  • Macrophages

  • Human monocyte-derived dendritic cells

  • Some subpopulations of mouse dendritic cells

• Barrier-forming cells:

  • Keratinocytes

  • Lymphatic and hepatic epithelium

  • Kidney mesangial cells

  • Tracheal smooth muscle

  • Retinal pigment epithelium

• Endothelial cells:

  • Hepatic endothelial cells

  • Lymphatic endothelial cells

Notably, MRC1 is not expressed on monocytes, which can serve as a distinguishing feature when characterizing cell populations .

How to select the optimal MRC1 antibody clone for specific research applications?

When selecting an MRC1 antibody for specific research applications, consider these factors:

• Application-specific performance:

  • For frozen section immunohistochemistry, clone 7-450 is specifically designed for this purpose

  • For flow cytometry and western blotting, clone 15-2 demonstrates excellent performance

  • For studies requiring detection across multiple species, rabbit polyclonal antibodies like bs-4727r offer reactivity with human, mouse, rat, and dog samples

• Epitope recognition:

  • Clone 15-2 recognizes an extracellular epitope of CD206

  • Some antibodies target specific amino acid ranges, such as bs-4727r targeting the 201-300/1456 range

• Species reactivity requirements:

  • If your research involves multiple species, select antibodies with cross-reactivity (e.g., bs-4727r shows reactivity with human, mouse, rat, and dog, with predicted reactivity to cow, sheep, pig, horse, chicken, and guinea pig)

• Conjugation needs:

  • For direct detection in flow cytometry, consider conjugated variants (PE or FITC)

  • For applications requiring signal amplification, unconjugated antibodies are preferable

What are the critical validation steps for MRC1 antibodies?

Validating MRC1 antibodies is essential for ensuring experimental reliability:

• Specificity testing:

  • Western blot analysis to confirm the antibody detects a protein of the expected molecular weight (162-175 kDa for MRC1)

  • Immunoprecipitation followed by mass spectrometry to verify target identity

  • Testing on known positive and negative cell types (e.g., macrophages versus monocytes)

• Purity assessment:

  • Verify antibody purity is >95% by SDS-PAGE

  • Check endotoxin levels are below acceptable thresholds (e.g., <0.01 EU/μg)

• Functional validation:

  • Confirm the antibody can detect changes in MRC1 expression during macrophage polarization

  • Verify expected staining patterns in tissues known to express MRC1, such as tonsil sections

• Cross-reactivity testing:

  • When working with polyclonal antibodies like bs-4727r, validate cross-reactivity with the specific species being studied

  • Test for non-specific binding to other C-type lectin receptors

How to optimize protocols for different applications of MRC1 antibodies?

Optimizing protocols for MRC1 antibody applications requires attention to several parameters:

• Flow cytometry optimization:

  • Use appropriate dilutions (1:20-100 for polyclonal antibodies like bs-4727r)

  • Include proper compensation controls if using conjugated antibodies

  • Consider fixation impact on epitope accessibility

  • Optimize permeabilization if targeting intracellular domains

• Western blotting considerations:

  • Test different dilution ranges (1:300-5000 for bs-4727r)

  • Optimize protein loading to ensure detection of the 162-175 kDa band

  • Select appropriate reducing or non-reducing conditions based on epitope requirements

• Immunohistochemistry optimization:

  • For frozen sections, clone 7-450 is specifically designed for this application

  • Optimize antigen retrieval methods to preserve epitope structure

  • Adjust blocking solutions to minimize background while preserving specific staining

• Storage and handling:

  • Follow manufacturer recommendations (e.g., storage at -20°C for one year with avoidance of repeated freeze/thaw cycles for bs-4727r)

  • Prepare working aliquots to minimize freeze-thaw cycles

What considerations are important for studying MRC1 in macrophage polarization research?

When studying MRC1 in the context of macrophage polarization:

• Polarization markers panel design:

  • Include MRC1 as part of a comprehensive panel for M2 macrophage identification

  • Consider co-staining with other M2 markers to confirm polarization state

  • Include appropriate M1 markers as controls

• Temporal dynamics:

  • Account for timing of MRC1 expression during the polarization process

  • Design time-course experiments to capture expression changes

• Microenvironmental factors:

  • Consider how culture conditions affect MRC1 expression

  • Account for matrix interactions that may modulate expression levels

• Functional correlation:

  • Link MRC1 expression to functional outcomes such as phagocytosis efficiency

  • Correlate expression levels with other functional parameters of M2 polarization

How to troubleshoot common issues with MRC1 antibody staining?

When encountering problems with MRC1 antibody staining, consider these troubleshooting approaches:

• Weak or absent signal:

  • Verify sample handling preserves MRC1 epitopes

  • Optimize antibody concentration (test titration series)

  • Enhance signal with amplification systems if necessary

  • Verify cells are properly fixed and permeabilized for intracellular epitopes

  • Check storage conditions of both antibody and samples

• High background:

  • Optimize blocking conditions to reduce non-specific binding

  • Increase washing steps and duration

  • Reduce antibody concentration if oversaturated

  • Use isotype controls to identify non-specific binding

  • Check for endogenous peroxidase or phosphatase activity in enzyme-based detection systems

• Inconsistent results between experiments:

  • Standardize cell culture conditions that might affect MRC1 expression

  • Maintain consistent antibody handling protocols

  • Use calibration beads for flow cytometry standardization

  • Maintain consistent lot numbers when possible

• Cross-reactivity issues:

  • Validate antibody specificity in your specific experimental system

  • Consider testing multiple antibody clones targeting different epitopes

What are the best practices for preserving MRC1 epitopes during sample preparation?

Preserving MRC1 epitopes during sample preparation requires careful attention to:

• Fixation methods:

  • Optimize fixation conditions to maintain epitope integrity

  • For flow cytometry, mild fixation with 1-2% paraformaldehyde may preserve epitopes better than harsher fixatives

  • For tissue sections, compare paraformaldehyde, acetone, or methanol fixation to determine optimal epitope preservation

• Temperature considerations:

  • Process samples promptly or store appropriately to prevent epitope degradation

  • Avoid extended periods at room temperature for live cells expressing MRC1

• Epitope retrieval techniques:

  • For FFPE tissue sections, test different antigen retrieval methods (heat-induced vs. enzymatic)

  • Optimize pH and buffer composition for antigen retrieval solutions

• Storage conditions:

  • For antibodies, follow manufacturer recommendations (e.g., store at -20°C, avoid freeze-thaw cycles)

  • For tissue samples, determine whether frozen storage or fixed preparation better preserves the epitope of interest

What methods can accurately quantify MRC1 expression levels?

Accurate quantification of MRC1 expression can be achieved through several methods:

• Flow cytometry quantification:

  • Use appropriate negative and positive controls to establish detection thresholds

  • Report data as mean fluorescence intensity (MFI) or percent positive cells

  • Consider quantitative flow cytometry using calibration beads to convert fluorescence to absolute antibody binding capacity

• Western blot quantification:

  • Include loading controls appropriate for your experimental design

  • Use digital imaging with linear dynamic range

  • Generate standard curves with recombinant MRC1 protein if absolute quantification is required

• qPCR for mRNA expression:

  • Design primers specific to MRC1 mRNA

  • Validate correlation between protein and mRNA levels in your experimental system

  • Use appropriate housekeeping genes for normalization

• Image analysis for immunohistochemistry:

  • Implement digital quantification of staining intensity

  • Use appropriate segmentation to distinguish positive from negative cells

  • Consider automated quantification tools to reduce subjective assessment

How to design multiplex studies incorporating MRC1 antibodies?

When designing multiplex studies with MRC1 antibodies:

What controls are essential for MRC1 antibody experiments?

Essential controls for MRC1 antibody experiments include:

• Antibody-specific controls:

  • Isotype controls matching the host species, isotype, and conjugation of the MRC1 antibody

  • Blocking peptide controls to demonstrate specificity

  • Secondary antibody-only controls to assess non-specific binding

• Biological controls:

  • Positive controls: Macrophages or other cells known to express MRC1

  • Negative controls: Monocytes or other cells known not to express MRC1

  • Polarization controls: M1 macrophages as negative/low expression controls versus M2 macrophages

• Technical controls:

  • Concentration-matched controls for optimal signal-to-noise ratio

  • FMO (fluorescence minus one) controls for flow cytometry panels

  • Unstained samples to establish autofluorescence baselines

• Validation controls:

  • siRNA or CRISPR knockdown of MRC1 to confirm antibody specificity

  • Recombinant MRC1 protein controls for antibody validation

How to interpret contradictory MRC1 detection results?

When faced with contradictory MRC1 detection results:

• Reconcile differences between techniques:

  • Consider the different sensitivities of various detection methods

  • Assess whether discrepancies arise from detecting different MRC1 epitopes

  • Evaluate whether sample preparation affects epitope accessibility differently across methods

• Analyze technical factors:

  • Compare antibody clones and their known epitopes

  • Assess fixation methods and their impact on epitope preservation

  • Evaluate detection systems and their sensitivity thresholds

• Consider biological variables:

  • Evaluate cell activation state and its effect on MRC1 expression

  • Assess microenvironmental factors that might modulate expression

  • Consider post-translational modifications that might affect antibody binding

• Resolution strategies:

  • Test multiple antibodies targeting different epitopes

  • Implement orthogonal detection methods (e.g., mass spectrometry)

  • Design functional assays to complement expression analysis